Cardiac rhythm management (CRM) plays a pivotal role in treating arrhythmias, which can manifest as palpitations, dizzy spells, blackouts, and sudden cardiac arrest.
CRM therapy encompasses implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices, serving as a cornerstone in the modern management of patients living with heart failure.
GDMTs and cardiac rhythm management devices are cornerstones of HFrEF management for eligible patients
CRM therapy is underused in real-world clinical practice